Mayne Pharma (ASX:MYX) Receives Court Approval for Acquisition Scheme
Mayne Pharma (ASX:MYX) receives Supreme Court approval for Cosette Pharmaceuticals’ acquisition scheme, leading to an upcoming shareholder vote.
Tag: Mergers & Acquisitions
Ridley Corporation Limited (ASX:RIC) Completes $99M Placement and Entitlement Offer
Ridley Corporation (ASX:RIC) successfully raises $99 million through institutional placement and entitlement offer to fund a strategic $300 million acquisition.
Clean Seas Seafood Limited (ASX:CSS) Court Approves Convening of Scheme Meeting
Clean Seas Seafood Limited (ASX:CSS) receives court approval for scheme meeting regarding Yumbah Aquaculture’s acquisition.
Southern Cross Media Group Limited (ASX:SXL) Challenges Sandon Capital’s Attempt to Remove Board Members
Southern Cross Media Group Limited (ASX:SXL) rebuffs Sandon Capital’s resolution attempts, highlights strong financial performance and plans to resume dividends.
Envirosuite Limited (ASX:EVS) Announces Acquisition by Ideagen Limited
Envirosuite (ASX:EVS) confirms acquisition by Ideagen Limited at a 109.3% premium, valuing the company at A$132.2 million.
AdNeo Limited (ASX: AD1) Acquires Learnt Global Group and Secures Equity Commitments
AdNeo Limited (ASX: AD1) acquires Learnt Global Group and secures $1.5m in equity commitments to drive revenue growth.
PointsBet Holdings Limited (ASX:PBH) Considers Acquisition Proposal from Betr Entertainment
PointsBet Holdings Limited (ASX:PBH) is evaluating an acquisition proposal from Betr Entertainment, considering it superior to the MIXI Scheme.
Yowie Group Limited (ASX:YOW) Announces Scrip Takeover Bid for Keybridge Capital Limited
Yowie Group Limited (ASX:YOW) announces a scrip takeover bid for Keybridge Capital Limited, offering 1 Yowie share for each KBC share.
Augustus Minerals (ASX:AUG) Acquires ACMPNG and Advances Mt Kare Gold Project License
Augustus Minerals (ASX:AUG) acquires ACMPNG to advance the Mt Kare Gold Project license application, strengthening its gold exploration portfolio.
MedAdvisor Limited (ASX:MDR) Provides Strategic Review Update
MedAdvisor Limited (ASX:MDR) announces a strategic review update, detailing a potential $35 million sale of its ANZ business division to a major software firm.